University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care

Hinton, W, McGovern, A, van Vlymen, J, Munro, N, Whyte, MB and de Lusignan, S (2016) Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care In: Diabetes UK Professional Conference 2016, 2016-03-02 - 2016-03-04, Scottish Exhibition and Conference Centre, Glasgow, 2-4 March 2016.

[img]
Preview
PDF (licence)
SRI_deposit_agreement.pdf
Available under License : See the attached licence file.

Download (33kB) | Preview

Abstract

Aim The use of glucagon-like peptide-1 (GLP-1) agonists in type 2 diabetes is increasing. We present a description of their current use and prescribing trends in UK primary care and compare the characteristics of people prescribed GLP-1 agonists with phase 3 trial populations.

Item Type: Conference or Workshop Item (Conference Poster)
Subjects : Nutrition
Divisions : Faculty of Health and Medical Sciences > School of Biosciences and Medicine > Department of Nutritional Sciences
Authors :
NameEmailORCID
Hinton, WUNSPECIFIEDUNSPECIFIED
McGovern, AUNSPECIFIEDUNSPECIFIED
van Vlymen, JUNSPECIFIEDUNSPECIFIED
Munro, NUNSPECIFIEDUNSPECIFIED
Whyte, MBUNSPECIFIEDUNSPECIFIED
de Lusignan, SUNSPECIFIEDUNSPECIFIED
Date : March 2016
Identification Number : 10.1111/dme.45_13048
Copyright Disclaimer : © 2016 John Wiley & Sons, Inc. All Rights Reserved.
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 18 Oct 2016 10:08
Last Modified : 18 Oct 2016 10:08
URI: http://epubs.surrey.ac.uk/id/eprint/812480

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800